The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia philadelphia + (CML-PH+) in accelerated phase (AP), comparison with chronic phase. a long-term retrospective study.
 
Rafael Hurtado-Monroy
No Relationships to Disclose
 
Berenice Vicente
No Relationships to Disclose
 
Diego Sarre-Alvarez
No Relationships to Disclose
 
Pablo Vargas-Viveros
No Relationships to Disclose
 
Montserrat Rojas
No Relationships to Disclose
 
Carlos Best
No Relationships to Disclose
 
Judith Cruz-Velazquez
No Relationships to Disclose
 
Myrna Candelaria
No Relationships to Disclose